Clinical Trial Update: GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

Final results from GRAVITAS-301, a Phase 3 study evaluating itacitinib plus corticosteroids versus placebo plus corticosteroids for acute graft-versus-host dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Graft-versus-host Disease (GVHD) | Phase 3 | Status: COMPLETED | Results posted: 2020-05-15